Alterity Therapeutics Stock Price History
ATHE Stock | USD 3.72 0.27 6.77% |
Below is the normalized historical share price chart for Alterity Therapeutics extending back to September 05, 2002. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Alterity Therapeutics stands at 3.72, as last reported on the 7th of January, with the highest price reaching 4.12 and the lowest price hitting 3.51 during the day.
If you're considering investing in Alterity Stock, it is important to understand the factors that can impact its price. Alterity Therapeutics is very risky given 3 months investment horizon. Alterity Therapeutics secures Sharpe Ratio (or Efficiency) of 0.26, which signifies that the company had a 0.26% return per unit of risk over the last 3 months. We have analyze and collected data for twenty-eight different technical indicators, which can help you to evaluate if expected returns of 1.94% are justified by taking the suggested risk. Use Alterity Therapeutics Risk Adjusted Performance of 0.211, mean deviation of 4.92, and Downside Deviation of 3.55 to evaluate company specific risk that cannot be diversified away.
At present, Alterity Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock is expected to grow to about 269.5 M, whereas Other Stockholder Equity is forecasted to decline to about 4.1 M. . At present, Alterity Therapeutics' Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 1.25, whereas Price Earnings Ratio is forecasted to decline to (0.90). Alterity Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of September 2002 | 200 Day MA 1.7221 | 50 Day MA 1.7756 | Beta 0.684 |
Alterity |
Sharpe Ratio = 0.2629
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ATHE | |||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
7.38 actual daily | 65 65% of assets are less volatile |
Expected Return
1.94 actual daily | 38 62% of assets have higher returns |
Risk-Adjusted Return
0.26 actual daily | 20 80% of assets perform better |
Based on monthly moving average Alterity Therapeutics is performing at about 20% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alterity Therapeutics by adding it to a well-diversified portfolio.
Price Book 4.3579 | Enterprise Value Ebitda 0.7546 | Price Sales 8.6791 | Shares Float 3.7 B | Wall Street Target Price 9 |
Alterity Therapeutics Stock Price History Chart
There are several ways to analyze Alterity Stock price data. The simplest method is using a basic Alterity candlestick price chart, which shows Alterity Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 3, 2025 | 4.26 |
Lowest Price | November 20, 2024 | 1.05 |
Alterity Therapeutics January 7, 2025 Stock Price Synopsis
Various analyses of Alterity Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Alterity Stock. It can be used to describe the percentage change in the price of Alterity Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Alterity Stock.Alterity Therapeutics Price Daily Balance Of Power | (0.44) | |
Alterity Therapeutics Accumulation Distribution | 14,408 | |
Alterity Therapeutics Price Rate Of Daily Change | 0.93 | |
Alterity Therapeutics Price Action Indicator | (0.23) |
Alterity Therapeutics January 7, 2025 Stock Price Analysis
Alterity Stock Price History Data
The price series of Alterity Therapeutics for the period between Wed, Oct 9, 2024 and Tue, Jan 7, 2025 has a statistical range of 3.21 with a coefficient of variation of 47.05. The prices are distributed with arithmetic mean of 1.7. The median price for the last 90 days is 1.28. The company had 1:10 stock split on 9th of January 2023.Open | High | Low | Close | Volume | ||
01/07/2025 | 3.95 | 4.12 | 3.51 | 3.72 | 97,310 | |
01/06/2025 | 4.40 | 4.40 | 3.87 | 3.99 | 195,578 | |
01/03/2025 | 3.76 | 4.71 | 3.74 | 4.26 | 224,375 | |
01/02/2025 | 3.35 | 3.75 | 3.28 | 3.73 | 68,473 | |
12/31/2024 | 3.40 | 3.45 | 3.02 | 3.31 | 72,363 | |
12/30/2024 | 3.10 | 3.88 | 3.01 | 3.50 | 199,138 | |
12/27/2024 | 3.05 | 3.37 | 2.89 | 3.14 | 116,889 | |
12/26/2024 | 2.46 | 3.16 | 2.46 | 3.15 | 121,839 | |
12/24/2024 | 2.40 | 2.60 | 2.40 | 2.45 | 37,474 | |
12/23/2024 | 2.21 | 2.47 | 2.20 | 2.40 | 62,190 | |
12/20/2024 | 2.06 | 2.25 | 2.05 | 2.20 | 26,532 | |
12/19/2024 | 2.10 | 2.15 | 2.05 | 2.10 | 13,015 | |
12/18/2024 | 2.25 | 2.26 | 2.04 | 2.16 | 37,598 | |
12/17/2024 | 2.25 | 2.28 | 2.13 | 2.27 | 38,993 | |
12/16/2024 | 2.40 | 2.45 | 2.25 | 2.31 | 30,816 | |
12/13/2024 | 2.33 | 2.40 | 2.21 | 2.40 | 44,033 | |
12/12/2024 | 2.35 | 2.35 | 2.18 | 2.22 | 37,805 | |
12/11/2024 | 2.21 | 2.33 | 2.19 | 2.27 | 57,935 | |
12/10/2024 | 2.40 | 2.40 | 2.12 | 2.32 | 90,904 | |
12/09/2024 | 2.19 | 2.50 | 2.19 | 2.48 | 205,372 | |
12/06/2024 | 2.07 | 2.19 | 2.00 | 2.15 | 103,833 | |
12/05/2024 | 1.99 | 2.19 | 1.90 | 1.94 | 192,972 | |
12/04/2024 | 1.65 | 2.20 | 1.62 | 1.88 | 345,269 | |
12/03/2024 | 1.54 | 1.64 | 1.46 | 1.60 | 56,126 | |
12/02/2024 | 1.41 | 1.65 | 1.41 | 1.52 | 219,340 | |
11/29/2024 | 1.16 | 1.50 | 1.16 | 1.41 | 854,281 | |
11/27/2024 | 1.08 | 1.09 | 1.06 | 1.09 | 5,751 | |
11/26/2024 | 1.10 | 1.10 | 1.06 | 1.06 | 6,092 | |
11/25/2024 | 1.10 | 1.15 | 1.05 | 1.05 | 16,431 | |
11/22/2024 | 1.09 | 1.11 | 1.00 | 1.07 | 38,252 | |
11/21/2024 | 1.09 | 1.10 | 1.07 | 1.07 | 9,597 | |
11/20/2024 | 1.10 | 1.11 | 1.05 | 1.05 | 16,670 | |
11/19/2024 | 1.09 | 1.13 | 1.09 | 1.12 | 3,403 | |
11/18/2024 | 1.09 | 1.12 | 1.08 | 1.10 | 10,661 | |
11/15/2024 | 1.24 | 1.24 | 1.10 | 1.11 | 13,122 | |
11/14/2024 | 1.29 | 1.29 | 1.15 | 1.17 | 9,744 | |
11/13/2024 | 1.27 | 1.27 | 1.16 | 1.18 | 13,221 | |
11/12/2024 | 1.14 | 1.18 | 1.14 | 1.16 | 8,804 | |
11/11/2024 | 1.16 | 1.19 | 1.14 | 1.19 | 7,199 | |
11/08/2024 | 1.23 | 1.23 | 1.14 | 1.16 | 12,510 | |
11/07/2024 | 1.18 | 1.19 | 1.14 | 1.18 | 33,561 | |
11/06/2024 | 1.24 | 1.24 | 1.19 | 1.22 | 35,765 | |
11/05/2024 | 1.18 | 1.19 | 1.17 | 1.18 | 6,299 | |
11/04/2024 | 1.17 | 1.17 | 1.14 | 1.14 | 2,747 | |
11/01/2024 | 1.15 | 1.18 | 1.11 | 1.17 | 13,121 | |
10/31/2024 | 1.17 | 1.17 | 1.10 | 1.15 | 7,292 | |
10/30/2024 | 1.16 | 1.18 | 1.12 | 1.18 | 22,666 | |
10/29/2024 | 1.25 | 1.25 | 1.15 | 1.16 | 3,797 | |
10/28/2024 | 1.17 | 1.19 | 1.14 | 1.15 | 6,061 | |
10/25/2024 | 1.18 | 1.20 | 1.16 | 1.16 | 4,924 | |
10/24/2024 | 1.19 | 1.19 | 1.14 | 1.17 | 8,580 | |
10/23/2024 | 1.19 | 1.20 | 1.14 | 1.17 | 20,099 | |
10/22/2024 | 1.22 | 1.23 | 1.20 | 1.20 | 12,265 | |
10/21/2024 | 1.25 | 1.26 | 1.20 | 1.22 | 17,019 | |
10/18/2024 | 1.24 | 1.26 | 1.23 | 1.26 | 10,822 | |
10/17/2024 | 1.25 | 1.28 | 1.20 | 1.20 | 9,142 | |
10/16/2024 | 1.26 | 1.26 | 1.22 | 1.25 | 6,241 | |
10/15/2024 | 1.26 | 1.26 | 1.23 | 1.26 | 8,917 | |
10/14/2024 | 1.28 | 1.29 | 1.25 | 1.25 | 6,101 | |
10/11/2024 | 1.30 | 1.32 | 1.23 | 1.29 | 23,946 | |
10/10/2024 | 1.25 | 1.30 | 1.23 | 1.28 | 2,928 |
About Alterity Therapeutics Stock history
Alterity Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alterity is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alterity Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alterity Therapeutics stock prices may prove useful in developing a viable investing in Alterity Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 4.2 B | 4.4 B | |
Net Loss | -12.4 M | -13 M |
Alterity Therapeutics Quarterly Net Working Capital |
|
Alterity Therapeutics Stock Technical Analysis
Alterity Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
All Next | Launch Module |
Alterity Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alterity Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Alterity Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alterity to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.211 | |||
Jensen Alpha | 1.8 | |||
Total Risk Alpha | 1.63 | |||
Sortino Ratio | 0.4993 | |||
Treynor Ratio | (3.98) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Alterity Stock analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Valuation Check real value of public entities based on technical and fundamental data |